Scientific News Health care Other illnesses and advices DIETARY CHANGE MAY PREVENT THE MOST SERIOUS FORM OF PROSTATE CANCER
DIETARY CHANGE MAY PREVENT THE MOST SERIOUS
FORM OF PROSTATE CANCER
Study suggests promising new
insights for men with early-stage disease
A fat-laden diet and high calcium
consumption are both well-known suspected risk factors for prostate cancer.
However, new findings from the Fred
Hutchinson Cancer Research Center suggest that fat
and calcium themselves may not cause prostate cancer, as previously thought, but
instead may fuel its progression from localized to advanced disease.
While high intake of dietary fat and calcium is
associated with an increased risk of clinically significant, advanced prostate
cancer, it has no apparent impact on risk of early-stage disease, according to
findings by Alan Kristal, Dr.P.H., and colleagues in Fred Hutchinson's Public
Health Sciences Division.
Results of this population-based, case-control
study appear today in Cancer Epidemiology, Biomarkers and Prevention, a journal
of the American Association for Cancer Research. The National Cancer Institute
and Fred Hutchinson funded the research.
"Our findings clearly show decreased risk
for late-stage disease in men with diets that are low in fat and moderate in
calcium, perhaps because these diets slow progression of prostate cancer into
more aggressive disease. For men diagnosed with early-stage prostate cancer,
this finding could be important because it suggests that moderating fat and
calcium consumption may reduce the risk of cancer recurrence following treatment,"
said Kristal, a member of Fred Hutchinson's Cancer Prevention Research Program.
This study looked at the associations of total
calorie, fat, calcium and vitamin D intake on prostate-cancer risk among 1,200
Seattle-area men ages 40 to 64; more than 60 percent of the participants were
under age 60. Half of the men had been recently diagnosed with prostate cancer
and the other half were healthy, randomly selected Puget Sound-area residents
who served as a comparison group. The men were interviewed about their dietary
habits three to five years prior to diagnosis (or an equivalent time frame among
the control group). They also completed a detailed dietary questionnaire that
asked how much and how often they consumed certain foods and dietary supplements.
While previous studies have examined similar
dietary factors on overall prostate-cancer risk, few studies have looked
specifically at risk comparing early with advanced disease.
While there is no effective treatment for
advanced prostate cancer, localized disease can be treated with either
prostatectomy or radiation therapy. While almost all men diagnosed with
early-stage prostate cancer survive for more than five years, only 34 percent of
men diagnosed after the disease has spread to distant organs are alive after
five years, according to the American Cancer Society.
"As more and more men are diagnosed with
early stage disease due to the widespread use of the PSA (prostate-specific
antigen) screening test, it becomes increasingly important to consider how
dietary or lifestyle changes could decrease their risk of cancer recurrence,"
said Kristal, also an associate professor of epidemiology at the University of
Washington School of Public Health and Community Medicine.
Kristal and colleagues found that men who ate
lower-fat diets, with fat accounting for no more than 30 percent of their daily
calorie intake, had half the risk of late-stage cancer than men who consumed
more fat. However, there were no associations of fat intake with early-stage
disease.
Saturated fats (found in meat and dairy fat) and
monounsaturated fats (found in certain oils, such as olive and peanut) were
associated with an increased risk of advanced prostate cancer. Polyunsaturated
fats (found in certain oils, such as safflower and canola) were not. Consumption
of omega-3 fatty acids (found in fatty fish such as salmon and mackerel) also
did not have an impact on overall prostate-cancer risk, contrary to experimental
studies in cell cultures that have suggested there may be a protective effect.
The U.S. Department of Agriculture's Dietary
Guidelines for Americans recommends no more than 30 percent of total daily
calories from fat. For example, a person who needs 2,000 calories a day based on
their height, weight and activity level would want to aim for no more than 600
calories from fat, or 65 grams (1 gram of fat has 9 calories, compared to only 4
calories in a gram of carbohydrate or protein).
One reason that low-fat diets could reduce the
risk of prostate cancer is because they reduce blood levels of circulating male
hormones such as testosterone. Growth of the prostate, and perhaps growth of
prostate cancer, is fueled by male hormones.
The researchers also found the risk of advanced
prostate cancer was 112 percent higher - more than double - among men who
consumed the most calcium (more than 1,200 mg per day, equivalent to four or
more glasses of milk) as compared to those who got the least (fewer than 500 mg).
It didn't matter whether the calcium came from food or supplements. "For
regional/distant disease, there were consistent trends for increased,
independent risks from both dietary and supplemental calcium," the
researchers wrote.
The mechanism underlying the effect of calcium on
prostate-cancer risk isn't clear, although there are relatively consistent
findings from previous studies suggesting that dairy products or
calcium-supplement intake are associated with risk. Some scientists hypothesize
that a high intake of calcium may suppress blood levels of the active form of
vitamin D, a hormone that may protect against prostate cancer by preventing the
development of cancerous cells.
The only dietary risk factor that appeared to
carry equal weight among men with both early and advanced prostate cancer was
the amount of total calories consumed, regardless of fat. "Total energy
intake was significantly associated with risk for both localized and advanced
disease," Kristal said. Men who ingested the most calories each day more
than doubled their risk of localized prostate cancer (a 115 percent increased
risk) and nearly doubled their risk of advanced prostate cancer (a 96 percent
increased risk) compared to men who ate the fewest.
"Our interpretation of these results is that
high energy intake increases prostate cancer risk overall, while high dietary
fat and calcium intakes increase the risk of more clinically significant,
advanced stages of the disease," the researchers wrote. "These results
are consistent with general dietary guidelines to moderate consumption of total
energy and fat, and they motivate further research to consider the potential
benefits and risks of high calcium intake."
One important implication of this research,
Kristal said, is that men who have been diagnosed with early-stage prostate
cancer may benefit from a diet low in fat and calories. "While there is an
increasingly popular message that fat intake is not important for health,"
he said, "there is no doubt that high-fat diets are associated with high
calorie intake and obesity. A low-fat diet may well be important for the
thousands of men who are diagnosed each year with early-stage prostate cancer."
Specific recommendations for calcium consumption
are more complex, because calcium also helps prevent osteoporosis and colon
cancer.
The U.S. Recommended Daily Intake of calcium for
men over age 50 is 1,200 mg. While the most well-known dietary sources of
calcium include milk, dairy products, salmon and dark, leafy greens, men -
particularly those taking calcium supplements - also should be aware of the
additional calcium content in fortified foods, from cereals to juices. A small
bowl of fortified cereal, for example, can contain up to 1,000 mg of calcium.
"Men diagnosed with early-stage prostate
cancer may wish to moderate their calcium intake, though the optimal level is
simply not known," Kristal said. "Much more research is needed on
factors that may prevent cancer recurrence in men treated for early-stage
disease."
###
The Fred Hutchinson Cancer Research Center,
home of two Nobel Prize laureates, is an independent, nonprofit research
institution dedicated to the development and advancement of biomedical
technology to eliminate cancer and other potentially fatal diseases. Fred
Hutchinson receives more funding from the National Institutes of Health than any
other independent U.S. research center. Recognized internationally for its
pioneering work in bone-marrow transplantation, the center's four scientific
divisions collaborate to form a unique environment for conducting basic and
applied science. Fred Hutchinson is the only National Cancer
Institute-designated comprehensive cancer center in the Pacific Northwest and is
one of 41 nationwide. For more information, visit the center's Web site at http://www.fhcrc.org/.
Advancing Knowledge, Saving Lives
Contact: Kristen Lidke Woodward, kwoodwar@fhcrc.org,
206-667-5095, Fred
Hutchinson Cancer Research Center
Source of the given news and the copyrights
belong to a Fred
Hutchinson Cancer Research Center
Publishing date: August 14, 2002
Back
|